Disclaimer | Privacy Policy | StemBook is published by IOS Press, Copyright © 2019
Copyright 2013 by the Massachusetts General Hospital. Some sections copyright 2008–2009 by The President and Fellows of Harvard College.
All content unless otherwise noted is licensed under a Creative Commons Attribution 3.0 Unported License
This content was originally published here.
The Menopause Association is a 501(c)(3) nonprofit organization committed to empowering women during the menopause transition and beyond. We offer evidence-based education, practical resources, and a supportive community to help women navigate this life stage with confidence and clarity. Through advocacy, expert-led initiatives, and holistic wellness programs, we work to destigmatize menopause, promote informed decision-making, and foster a vibrant network where women can connect, learn, and thrive.
On July 17, 2025, the U.S. Food and Drug Administration (FDA) hosted a landmark expert panel to address longstanding controversies surrounding hormone replacement therapy (HRT)
Dr. Howard Hodis, professor of medicine and a landmark figure in cardiovascular research, delivered a thorough analysis of how HRT timing determines its effect profile.
Dr. Rachel S. Rubin, fellowship-trained urologist and sexual medicine expert, used her time to elevate the discussion around genital and urinary syndrome of menopause (GSM).
Mary Jane Minkin, MD, veteran OB/GYN and menopause educator, presented a comprehensive critique of the “one-size-fits-all” black box warning on estrogen therapies, focusing especially on
Dr. Kelly Casperson brought a unique perspective as a urologist and sexual health expert, focusing attention on the regulatory and clinical neglect faced by women
Dr. Vonda Wright, a leading authority on musculoskeletal health and aging, offered a no-nonsense appraisal of estrogen’s role in maintaining bone health after menopause. Describing
